<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 31 Mar 2021 07:22:35 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>化学药物生产现场检查问答总结</title><link>https://mp.weixin.qq.com/s/CihbWH7WPPi38LuRE0nv_w</link><description></description><content:encoded><![CDATA[化学药物生产现场检查问答总结]]></content:encoded><pubDate>Tue, 30 Mar 2021 20:48:17 +0800</pubDate></item><item><title>全球首个BCMA CAR-T疗法获批上市！治疗多发性骨髓瘤</title><link>https://mp.weixin.qq.com/s/dPLYmHIr5DgVXyuLw1DJug</link><description></description><content:encoded><![CDATA[全球首个BCMA CAR-T疗法获批上市！治疗多发性骨髓瘤]]></content:encoded><pubDate>Tue, 30 Mar 2021 20:48:17 +0800</pubDate></item><item><title>聚焦小分子创新药FIC，罗氏/海思科/恒瑞/交大/复旦...PharmaCon首批嘉宾阵容曝光</title><link>https://mp.weixin.qq.com/s/t3_PSlQ9p0_R-mLSMmB4-A</link><description></description><content:encoded><![CDATA[聚焦小分子创新药FIC，罗氏/海思科/恒瑞/交大/复旦...PharmaCon首批嘉宾阵容曝光]]></content:encoded><pubDate>Tue, 30 Mar 2021 20:48:17 +0800</pubDate></item><item><title>对&#34;生产工艺变更”那些有的没的...</title><link>https://mp.weixin.qq.com/s/uZNbgLRWw63Ab2sNZg8mRA</link><description></description><content:encoded><![CDATA[对"生产工艺变更”那些有的没的...]]></content:encoded><pubDate>Tue, 30 Mar 2021 20:48:17 +0800</pubDate></item><item><title>药物免疫原性研究技术指导原则</title><link>https://mp.weixin.qq.com/s/ILvq3RsCIdFICRO_mX9YKw</link><description></description><content:encoded><![CDATA[药物免疫原性研究技术指导原则]]></content:encoded><pubDate>Mon, 29 Mar 2021 19:39:39 +0800</pubDate></item><item><title>FDA培训PPT： 工艺验证与ICHQ7</title><link>https://mp.weixin.qq.com/s/8GRS5Y4Cpi_jnjz1iQ_NQQ</link><description></description><content:encoded><![CDATA[FDA培训PPT： 工艺验证与ICHQ7]]></content:encoded><pubDate>Mon, 29 Mar 2021 19:39:39 +0800</pubDate></item><item><title>一图看懂康龙化成2020年年报</title><link>https://mp.weixin.qq.com/s/TCHbXZnxXchzhXnKxQJZ9A</link><description></description><content:encoded><![CDATA[一图看懂康龙化成2020年年报]]></content:encoded><pubDate>Mon, 29 Mar 2021 19:39:39 +0800</pubDate></item><item><title>集采迫近！生物类似药该怎样与原研“争雄天下”？</title><link>https://mp.weixin.qq.com/s/0hAx2s61xu-2DQrtReehwA</link><description></description><content:encoded><![CDATA[集采迫近！生物类似药该怎样与原研“争雄天下”？]]></content:encoded><pubDate>Mon, 29 Mar 2021 19:39:39 +0800</pubDate></item><item><title>严重副作用不同疾病的对应手册（面向患者·公众）（60）-周围神经病变</title><link>https://mp.weixin.qq.com/s/T03A1fmFJH1hSaTgNLXA-Q</link><description></description><content:encoded><![CDATA[严重副作用不同疾病的对应手册（面向患者·公众）（60）-周围神经病变]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:53:11 +0800</pubDate></item><item><title>药品专利期限补偿制度红利能否惠及已上市新药引关注专家建议</title><link>https://mp.weixin.qq.com/s/o2hnd8YYu4U4wjIzl6Ss0g</link><description></description><content:encoded><![CDATA[药品专利期限补偿制度红利能否惠及已上市新药引关注专家建议]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:53:11 +0800</pubDate></item><item><title>种族差异性药物桥接境外临床研究数据辅助新药审评工作的启示——以盐酸胍法辛在日本上市为例</title><link>https://mp.weixin.qq.com/s/2HDTQmise784RLBVCU6jeQ</link><description></description><content:encoded><![CDATA[种族差异性药物桥接境外临床研究数据辅助新药审评工作的启示——以盐酸胍法辛在日本上市为例]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:53:11 +0800</pubDate></item><item><title>CDE常见一般性技术问题124个问题解答</title><link>https://mp.weixin.qq.com/s/sIUVBHyQkgKKHaQePOaaJg</link><description></description><content:encoded><![CDATA[CDE常见一般性技术问题124个问题解答]]></content:encoded><pubDate>Sat, 27 Mar 2021 22:01:35 +0800</pubDate></item><item><title>美国仿制药立项调研及评估</title><link>https://mp.weixin.qq.com/s/q3aZYjKg9KnHzKDPLZvN8A</link><description></description><content:encoded><![CDATA[美国仿制药立项调研及评估]]></content:encoded><pubDate>Sat, 27 Mar 2021 22:01:35 +0800</pubDate></item><item><title>NMPA发布《医疗器械注册管理办法（修订草案征求意见稿）》</title><link>https://mp.weixin.qq.com/s/X9cq7DX5iADeOxFuSwnrkw</link><description></description><content:encoded><![CDATA[NMPA发布《医疗器械注册管理办法（修订草案征求意见稿）》]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:46 +0800</pubDate></item><item><title>双抗，下一代抗体药物</title><link>https://mp.weixin.qq.com/s/nqgnXXxGwgsIRli_fBMyNw</link><description></description><content:encoded><![CDATA[双抗，下一代抗体药物]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:46 +0800</pubDate></item><item><title>“现货”CAR-T细胞疗法引领全球浪潮</title><link>https://mp.weixin.qq.com/s/zWgB0uel6KO0shwPVFUL-A</link><description></description><content:encoded><![CDATA[“现货”CAR-T细胞疗法引领全球浪潮]]></content:encoded><pubDate>Fri, 26 Mar 2021 23:39:46 +0800</pubDate></item><item><title>无菌生产工艺验证的主要内容与方法</title><link>https://mp.weixin.qq.com/s/aVl8z7armTvyV4SLWhCKPA</link><description></description><content:encoded><![CDATA[无菌生产工艺验证的主要内容与方法]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:57:34 +0800</pubDate></item><item><title>小分子药物研发中代谢产物非临床研究的关注要点</title><link>https://mp.weixin.qq.com/s/0yptUk_PM4ynSMRyyyGiCA</link><description></description><content:encoded><![CDATA[小分子药物研发中代谢产物非临床研究的关注要点]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:57:34 +0800</pubDate></item><item><title>大脑里5个肿瘤消失了！CAR-T细胞疗法见证奇迹</title><link>https://mp.weixin.qq.com/s/IwD2tqsuG6rV7yJZaj-bcw</link><description></description><content:encoded><![CDATA[大脑里5个肿瘤消失了！CAR-T细胞疗法见证奇迹]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:57:34 +0800</pubDate></item><item><title>走进Lonza，聊一聊药物早期开发的那些事儿</title><link>https://mp.weixin.qq.com/s/_RXxjxi4xcuAiTV5kDcdjA</link><description></description><content:encoded><![CDATA[走进Lonza，聊一聊药物早期开发的那些事儿]]></content:encoded><pubDate>Thu, 25 Mar 2021 19:57:34 +0800</pubDate></item></channel></rss>